ArticlePharmaceuticals (Basel, Switzerland)2022

Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice.

Jin-Yu Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.